With significant growth over the past year, Andrew brings a wealth of experience in both manufacturing and life sciences to ably steer the strategic direction of the company, and maximize value for its shareholders.
Andrew trained as a Chemical and Process Engineer and then spent 12 years in the Biotech and Pharmaceutical Industries in the UK. His experience spanned manufacturing, engineering, business development and R&D. He was a Director and part of the executive management team that executed a successful turnaround of a small, fully integrated, speciality pharmaceutical company (Allergy Therapeutics plc) and subsequent listing on the London Stock Exchange.
View LinkedIn Profile